Johnson & Johnson edges closer to $24bn Guidant deal

Johnson & Johnson, the US healthcare company, is closing in on a $24bn (€18bn) acquisition of Guidant, a domestic rival, and may reach an agreement in the next few days.

The company, which is the world's biggest maker of medical devices, has held extended negotiations with Guidant, forcing a delay in a deal being signed.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump